News
0
Roche has unveiled new Phase 1/2 data for its selective tyrosine kinase inhibitor entrectinib, demonstrating its ability to shrink recurrent or...
0
Gilead, Janssen and BMS accused of forging anticompetitive deal; Novartis buy Takeda's dry eye drug Xiidra for $5.3 billion; NHS England to pay for...
0
The FDA has announced its approval of Pfizer’s anticoagulant injection Fragmin (dalteparin sodium) for subcutaneous use as a treatment to reduce...
0
US Representative Alexandria Ocasio-Cortez tore into Gilead CEO Daniel O’Day on Thursday, over the firm’s nearly $2,000 price tag on PrEP drug,...
Features
“If you are looking to make a difference in how business is done, perseverance and patience are crucial”
Featured Appointment
Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr...
Service Company News
Featured Event
25/09/2019 - 26/09/2019 -
London,
@Pharmafocus
